- Open Access
Antihyperlipidemic efficacy of aqueous extract of Stevia rebaudiana Bertoni in albino rats
Lipids in Health and Diseasevolume 17, Article number: 175 (2018)
Stevia (Stevia rebaudiana Bertoni) natural, safe, non-toxic, non-caloric sugar substitute is rich source of pharmacologically important glycoside stevioside that is linked to the pathology and complications of hyperlipidemia.
The present research was carried out to explore the anti-hyperlipidemic effect of aqueous extract of Stevia rebaudiana Bertoni leaves in albino rats. For this purpose, hyperlipidemia was induced by administration of Cholesterol (90% E, Appli Chem, Darmstadt, Germany) mixed at dose of 400 mg/kg body weight of rats in their daily routine feed. The hyperlipidemic rats were administered with aqueous stevia extract at different dose levels (200, 300, 400 and 500 ppm/kg b.w.) for 8 weeks; the control rats were fed basal diet during this period. Ethical approval for the current research was obtained from Institutional Review Board Faculty of Science & Technology Government College University, Faisalabad, Pakistan.
Stevia aqueous extract decreased the body weight gain by lowering the feed intake of hyperlipidemic rats. Furthermore, administration of stevia extract at different levels significantly (P < 0.05) lowered the TC (125.22 ± 5.91 to 110.56 ± 5.81 mg/dL), TG (102.13 ± 6.89 to 98.62 ± 7.22 mg/dL), LDL (33.02 ± 4.79 to 22.77 ± 4.36 mg/dL), VLDL (21.22 ± 5.79 to 19.33 ± 5.95 mg/dL) levels and LDL/HDL ratios (0.83 ± 1.22 to 0.54 ± 1.66 mg/dL) from H1 to H4. Conversely, it improved the HDL (39.76 ± 4.34 to l42.02 ± 4.39 mg/dL) level in hyperlipidemic rats compared with untreated rats after eight weeks study period.
It is concluded that aqueous extract of stevia has anti-hyperlipidemic effects in albino rats, and therefore could be a promising nutraceutical therapy for the management of hyperlipidemia and its associated complications.
Hyperlipidemia is a heterogeneous disorder characterized by an elevation of total cholesterol, triglycerides, very low density lipoprotein cholesterol, low-density lipoprotein cholesterol, free fatty acids and apolipoprotein B levels, as well as reduced high-density lipoprotein cholesterol levels . Among these, hypercholesterolemia and hypertriglyceridemia are closely related to ischemic heart disease. Hyperlipidemia is a common predicament in society due to change of lifestyle and food practice. Proper diet containing low fat, exercise and medication plays an important role in the prevention and treatment of increased lipid profile. Moreover, synthetic drugs are mostly used for the management of hyperlipidemia but consumption of these drugs for long period of time results in health problems such as diarrhea, liver and kidney problems due to their toxic effect. Therefore, people are more interested in using traditional medicinal plants due to their natural origin, safe and non-toxic nature . Stevia rebaudiana Bertoni (family Asteraceae) popularly known as stevia, sweet weed, honey leaf and sweet herb of Paraguay . It is natural, safe, non-toxic, non-calorie medicinal herb that has hypolipidemic ability due to presence of glycosides including stevioside, steviolbioside, rebaudiosides (A, B, C, D, E) and dulcoside A but the major sweet constituents are stevioside and rebaudioside A [4, 5]. Natural non-caloric sweetener stevioside (a major component of stevia) is 100–300 times sweeter than sucrose and have been extensively used as a non-caloric sugar substitute in many kinds of foods, medicine, beverage, cosmetics, wine making, household chemical industry and other food industries . Besides hypolipidemic effect, it also posses anti-hyperglycaemic, anti-hypertensive, anti-oxidant, anti-tumor, anti-diarrheal, diuretic, gastro- and renal-protective anti-viral and immunomodulatory properties . The hypolipidemic effect of stevia has been proven in both humans and rats. According to previous literature [8, 9] stevia extract has ability to reduce total cholesterol, triglycerides, low density lipoprotein and very low density lipoprotein. Moreover, it increased the level of high density lipoprotein.
As the Stevia rebaudiana Bertoni is safe and non-toxic natural herb and can be a better alternative of synthetic medicines used for the treatment of hyperlipidemia. Hence, the current research was carried out to investigate the hypolipidimic potential of Stevia rebaudiana Bertoni in albino rats.
Collection of material
Stevia (Stevia rebaudiana Bertoni) leaves were collected from Ayub Agricultural Research Institute (AARI), Faisalabad, Pakistan.
Procurement of raw material
Stevia (Stevia rebaudiana Bertoni) leaves were washed to remove the dirt, dust and foreign material present on the surface. After washing, leaves of stevia were spread on trays and dried under shade at room temperature ranged from to 25–30 °C for 24–48 h. Then dried leaves were grinded into fine powder with the help of grinder (MJ-176-NR-3899) .
Preparation of stevia aqueous extract
Stevioside was extracted from the dried ground stevia leaves by using water extraction. The dried ground leaves of stevia were mixed with hot water (65 °C) at the ratio of 1:45 (w/v) and extracted for 3 h. The crude extract containing stevioside were filtered through What man No. 1 filter paper and then evaporated to dryness by using rotary vacuum evaporator (EYELA N-1110 S 115 V) at 40–45 °C .
Sixty adult male albino rats of average weight 153.88 g were purchased from National Institute of Health, Islamabad, Pakistan and kept in stainless steel cages under standard conditions (temperature 25 ± 2 °C and 60 ± 5% relative humidity with 12 h light-dark cycle) in environmentally controlled animal house of college of pharmacology, Faculty of Science and Technology, Government College University Faisalabad Pakistan. The rats were acclimatized by feeding freshly prepared basal diet containing 65% starch, 10% casein, 10% corn oil, 4% salt mixture, 1% vitamins mixture and 10% cellulose  and distilled water for two weeks.
Induction of hyperlipidemia
Hyperlipidemia was induced in albino rats with cholesterol (Cholesterol 90% E, Appli Chem, Darmstadt, Germany) which was mixed at dose of 400 mg/kg body weight of rats in their daily routine feed. All the experimental groups were fed on high cholesterol feed (Normal rat feed + Cholesterol) for first 15 days. H0 (hyperlipidemic control group) was kept on high cholesterol feed while normal control group rats (N0) fed on standard basal diet and distilled water throughout the experimental period (8 weeks) . For the experiment stevia aqueous extract at the dose levels of 200, 300, 400 and 500 ppm/kg body weight was dissolved in the distilled water of treated hyperlipidemic rats groups and given them orally with graduated feeding bottle on daily basis.
Animal groups and experimental design
Sixty male albino rats were divided into six groups of ten animals each and aqueous stevia extract was added in the distilled water of rats at different substitution levels given in Table 1.
Feed and water intake
Net feed intake of individual rat was calculated on daily basis by excluding left-over and collected spilled diet during the entire period to determine the effect of individual experimental diet. Water was provided with the help of graduated drinking bottles and its consumption was also measured on daily basis.
Gain in body weight
Gain in body weight of individual rat in each group was estimated on weekly basis throughout the study period to find out the effect of treatments on body weight using electronic weighing balance (KERN 440-35 N).
Collection of serum of rats
After the 8 weeks of study period, the overnight fasted albino rats were killed using urethane anesthesia. The blood was collected by cardiac puncture and was centrifuged in the centrifuge machine (LABCENT 5000) at 3000 rpm for 15 min after allowing the blood to stand for at least 30 min at room temperature as explained by .
Serum lipid profile
Serum lipid profile including total cholesterol, triglycerides, high density lipoproteins, low density lipoproteins, very low density lipoproteins and LDL/HDL ratio were measured by using auto chemistry analyzer (Rayto RT 9200) in order to observe the variation in plasma lipid profile due to administration of aqueous stevia extract according to their respective protocols. The detail of their procedures is given below:
Total cholesterol level
Serum cholesterol level was determined using CHOD–PAP method following the method of .
Total triglycerides in all serum samples were determined by liquid triglycerides (GPO–PAP) method as outlined by .
High density lipoprotein level
High density lipoprotein (HDL) in serum samples was measured by HDL Cholesterol Precipitant method as mentioned by .
Low density lipoprotein and very low density lipoproteins levels
Low-density lipoproteins (LDL) and very low-density lipoproteins (VLDL) levels were calculated by using the Friedewald formula  as follows:
LDL = TC–(HDL + VLDL)
VLDL = TRIG/5
Effect of stevia aqueous extract on LDL/HDL ratio of rats was also observed by dividing LDL and HDL.
The data regarding results of present research was statistically analyzed using mixed model (general linear model) by analysis of variance (ANOVA) using Minitab 17 software package. The level of significance between the mean values of samples was determined by least significant difference (LSD) .
It is apparent from the results that different levels of stevia aqueous extract and study period (8 weeks) significantly affected feed intake, water intake and gain in body weight of normal and hyperlipidemic albino rats.
Mean values for feed intake in different groups of rats (g/rat/day) have been shown graphically in Fig. 1. The results demonstrated that administration of stevia sweetener reduced the feed intake in hyperlipidemic rats as compared to normal and hyperlipidemic groups. According to results feed intake of N0 and H0 increased from 16.72 ± 1.28 and 17.00 ± 1.30 g/rat/day at 1st week to 18.32 ± 1.76 and 20.05 ± 1.54 g/rat/day respectively at 8th week. In the case of stevia aqueous extract treated hyperlipidemic groups, the feed intake decreased as function of time and at 1st week feed intake in H1, H2, H3 and H4 was 16.22 ± 1.14, 15.87 ± 1.43, 15.12 ± 1.04 and 14.72 ± 1.22 g/rat/day that decreased to 14.20 ± 1.02, 13.62 ± 1.23, 12.44 ± 1.00 and 11.82 ± 1.32 g/rat/day respectively at 8th week.
Means belonging to water intake as presented in Fig. 2, showed that at 1st week it was 27.7 ± 1.01 and 27.97 ± 0.98 mL/rat/day in N0 and H0 that increased to 29.21 ± 0.34 and 30.62 ± 1.04 mL/rat/day, correspondingly at 8th week. While in H1, H2, H3 and H4 the water intake decreased from 27.00 ± 1.03, 26.50 ± 0.92, 25.80 ± 0.57 and 25.22 ± 0.87 mL/rat/day at 1st week to 25.32 ± 0.99, 24.7 ± 0.87, 24.15 ± 0.45 and 23.4 ± 0.76 mL/rat/day at 8th week respectively.
Body weight gain
Effect of administration of stevia sweetener on the weight gain in rats has been shown in Table 2. It is apparent from the results that the highest gain in body weight was observed in hyperlipidemic group (H0) from 158.64 ± 4.32 g/rat at 1st week to 195.26 ± 4.50 g/rat at 8th week. While the lowest gain in body weight (150.22 ± 6.30 to 124.77 ± 7.80 g/rat) was observed in H4 (rats received 500 ppm/kg b.wt stevia aqueous extract) followed by H1, H2 and H3 from 1st to 8 weeks.
The results regarding body weight gain percentage (BWG %) depicted that the highest BWG % (26.95%) was observed in H0. On the other hand, when hyperlipidemic rats were given stevia sweetener at doses of 200, 300, 400 and 500 ppm/kg b. wt then their body weight gain BWG % decreased by − 13.58, − 15.44, − 17.89 and − 18.47% respectively after eight weeks (Table 3).
Serum lipid profile
Total cholesterol level
Table 4 shows that stevia aqueous extract significantly (P < 0.05) affected the total cholesterol levels of hyperlipidemic rats. The results found that highest value was observed in hyperlipidemic group (H0) (150.55 ± 7.83 mg/dL). While total cholesterol of hyperlipidemic rats treated with stevia significantly reduced to 125.22 ± 5.91 mg/dL in H1, 121.63 ± 56.81 mg/dL in H2, 116.17 ± 5.89 mg/dL in H3 and 110.56 ± 5.81 mg/dL in H4. It is obvious from results that stevia aqueous extract decreased the cholesterol levels by 2.96, 5.74, 9.98 and 14.32% in H1, H2, H3 and H4 when rats were given stevia sweetener at doses of 200, 300, 400 and 500 mg/kg/b. wt, respectively at eight weeks study period.
The mean values for triglyceride levels in normal and hyperlipidemic groups are given in Table 4. The results confirmed that highest value of triglycerides was found in H0 (107.90 ± 5.88 mg/dL), while lowest value was observed in H4 (98.62 ± 7.22 mg/dL) followed by other groups (H1, H2 and H3. It is confirmed from the results that triglycerides levels of hyperlipidemic rats received stevia aqueous extract at levels of 200, 300, 400 and 500 mg/kg/b. wt in H1, H2, H3 and H4 decreased by 0.93, 1.91, 3.86 and 4.33% respectively as compared to normal group (N0) at eight weeks study period.
High density lipoprotein level
The mean values for HDL as presented in Table 4 showed that level of high density lipoprotein in hyperlipidemic rats was significantly affected by different levels of stevia aqueous extracts. According to results lowest value of HDL was observed in H0 while that value increased in H1 (39.76 ± 4.34 mg/dL), H2 (40.13 ± 4.74 mg/dL), H3 (41.14 ± 4.38 mg/dL) and H4 (42.02 ± 4.39 mg/dL) with increasing the concentration of stevia aqueous extracts.
Low density lipoprotein level
The data presented in Table 4 indicated that low density lipoprotein (LDL) levels in hyperlipidemic rats were significantly (P < 0.05) affected by different levels of aqueous stevia extract. According to results, highest value for LDL was observed in H0 (55.49 ± 3.88 mg/dL), while lowest value was recorded in H4 (22.77 ± 4.36 mg/dL) as compared to H1, H2 and H3. Furthermore, the results revealed that LDL levels in H1, H2, H3 and H4 decreased by 6.56, 12.50, 21.27, 35.56% respectively as compared to normal group (N0) (Table 4).
Very low density lipoprotein level
Table 4 illustrated that very low density lipoprotein (VLDL) level in different groups of rats was considerably affected by treatments. The results confirmed that the highest value of VLDL was observed in hyperlipidemic group (H0). However very low density lipoprotein levels of hyperlipidemic rats administrated with stevia decreased (21.22 ± 5.79 mg/dL) in H1, (20.72 ± 8.79 mg/dL) in H2, 20.56 ± 7.75 mg/dL) in H3 and (19.33 ± 5.95 mg/dL) in H4. The results depicted that stevia aqueous extract decreased the VLDL levels in H1, H2, H3 and H4 by 16.19, 20.87, 26.39 and 31.12% respectively as compared to normal group rats (N0).
The mean values for LDL/HDL ratios (Table 4) in normal and hyperlipidemic groups demonstrated that the highest value of LDL/HDL ratio was found in H0 (1.49 ± 0.73 mg/dL). However, lowest value of LDL/HDL ratio was observed in H4 (0.54 ± 1.66 mg/dL) followed by H1, H2 and H3.
The results regarding feed intake of different groups of rats found that H0 (Hyperlipidemic group) had higher feed intake due to high-fat diet given to them that increased their energy intake and energy storage . While the hyperlipidemic rats that received stevia aqueous extract consumed less feed due to stevioside presence in it that may not stimulate the appetite of rats . The results of current research work is supported by the findings of  who reported that stevia extract may reduced the feed intake because it is low-caloric sweetener that may not increase calorie intake and don’t stimulate appetite. Furthermore,  demonstrated that Portulaca oleracea stem may reduce the feed intake of hyperlipidemic wister albino rats.
Water intake of hyperlipidemic rats reduced after administration of stevia aqueous extract due to glycoside (stevioside) in stevia extract that decreased the water consumption of rats. The findings of present study are in collaborations with work of  who illustrated that hyperlipidemic rats that received stevia aqueous extract consumed less water than control group rats (normal and hyperlipidemic). Afterwards, [1, 22] found that stevia aqueous extract may reduce the water intake of hyperlipidemic albino rats.
The body weight gain of different groups of rats showed that hyperlipidemic group gained higher body weight due to high fat diet (cholesterol) used to induce hyperlipidemia in the rats that increased energy intake and energy storage .
When hyperlipidemic rats were given stevia sweetener at doses of 200, 300, 400 and 500 ppm/kg b. wt then their body weight gain decreased. The decrease in body weight gain was due to capability of stevioside in stevia extract that decreased the food intake of rats. Furthermore, stevioside may also reduce the body weight gain by decreasing the glucose level and promote insulin sensitivity . Another reason for the decrease of body weight gain was due to stevioside ability to decrease the fat absorption and lipogenic enzymes and increase the fat excretion . The results of current research are in line with [25,26,27] who found that there is a positive association between the decrease of body weight gain and dose of stevioside given to the rats. The body weight of rats decreased by increasing the concentration of stevioside in their diets.
The results of total cholesterol levels of different groups of rats depicted that TC level of H0 (hyperlipidemic group) had highest value. Conversely, addition of stevia aqueous extract at different levels lowered the TC levels in H1, H2, H3 and H4. Stevia aqueous extract contained stevioside that significantly lowered total cholesterol level due to its ability to increase the bile acid excretion by preventing reabsorption from small intestine through disruption of micelle formation of bile acid. The increase in excretion of bile acid and cholesterol activates cholesterol 7α-hydroxylase that enhances the conversion of liver cholesterol to bile acid thus resulting in cholesterol reduction . The present research is in accordance with [22, 29,30,31] according to them mechanism for reducing cholesterol level is due to the stevioside which binds the biliary or dietary cholesterol in the colon and increases the fecal excretion of the bile acids. The increased action of 3-hydroxy-3-methylglutaryl CoA reductase (HMG-CoA) may stimulate the hepatic cholesterogenesis.
The data presented in Table 4 shows that concentration level of stevia supplementation had significant factor in lowering triglycerides in hyperlipidemic rats. In current research the increased level of triglycerides in H0 might be due to enhanced expression of enzymes including acetyl-coenzyme A carboxylase and fatty acid synthase, involved in TG synthesis. Moreover, malic enzyme was increased that supplies NADPH for the synthesis of long-chain fatty acids.
While in hyperlipidemic rats administrated with stevia aqueous extract, the TG levels decreased due to stevioside (major glycoside in stevia) that enhance the activity of lipase enzyme produced by liver that resulted in catabolism of lipids. Low concentration of triglycerides may also due to inhibition of dietary lipid absorption in the intestine by reducing micellar solubilization of cholesterol and by increasing excretion of TG via feces . The hypolipidemic property of stevia might also be explained by interaction between stevia consumption and activation of peroxisome proliferators-activated receptors (PPARs). PPARs as a regulatory factor in lipogenesis process activate the expression of the lipoprotein lipase (LPL) and apo C-II genes as well as the hepatic uptake and etherification of free fatty acids, along with increasing mitochondrial free fatty acid oxidation . The results of present research are also confirmed by the research works of [22, 26, 27, 33] who found that stevioside significantly lowered the triglyceride level as compared to untreated rats due to stevioside in stevia that reduced the activity of acetyl-coenzyme A carboxylase and fatty acid synthase.
The mean values for high density lipoprotein (HDL) levels of hyperlipidemic rats illustrated that lowest HDL level was observed in hyperlipidemic group and highest value of HDL was determined in H4. According to findings of present research the increase in the HDL levels of hyperlipidemic rats received stevia aqueous extracts at different levels was due to stevioside in stevia aqueous extract that improved the HDL level as compared to untreated rats. HDL (good form of lipid profile) is involved in transfer of cholesterol from tissues and arteries back to liver, thus reduced deposited cholesterol in the endothelium by retrieving cholesterol from peripheral cells and other lipoproteins to the liver for excretion in the bile and prevented LDL accumulation in the walls of the arteries [22, 32, 33]. Furthermore, [22, 26] found that stevia aqueous extract increased the HDL level in albino rats due to the elevation in the lecithin cholesterol acyl transferase (LCAT) activity which may attribute to the blood lipids regulation.
Low density lipoprotein (LDL) levels of different groups of rats demonstrated that stevia aqueous extract decreased the LDL levels in hyperlipodemic rats. The stevioside in stevia aqueous extract significantly lowered the LDL levels in hyperlipidemic rats by up regulating LDL receptor. The increase in the LDL receptor improves the uptake of low density lipoprotein cholesterol from the blood circulation [33, 34]. The findings of current research are in agreement with the studies of [1, 22] who found that stevia aqueous extract and Portulaca oleracea L. stem lowered the LDL level in rats because stevioside in stevia aqueous extract increase the LDL receptor and modulate cholesterol metabolism.
Very Low density lipoprotein (VLDL) levels of hyperlipidemic rats decreased after the administration of stevia aqueous extract at different dose levels due to glycoside (stevioside) in stevia extract that lowered the VLDL levels in hyperlipidemic rats. The results of present research work are in line with the work of [20, 33] who demonstrated that stevioside and solanum species (egg plant) significantly decreased the VLDL. Similary,  depicted that methanolic leaf extract of Stevia rebaudiana significantly decreased the VLDL-C levels in alloxan induced diabetic mice. Furthermore, [22, 35] illustrated that stevia aqueous extract and Portulaca oleracea L. stem lowered the VLDL level in rats.
The mean values for LDL/HDL ratios (Table 4) in hyperlipidemic rats demonstrated that the highest value of LDL/HDL ratio was determined in hyperlipidemic group. While, LDL/HDL ratios decreased in hyperlipidemic rats received stevioside present in stevia aqueous extracts. The results of current research are in accordance with the findings of [22, 36] who found that stevia aqueous extract and two carotenoids (lycopene and β-Carotene) supplementation lowered the LDL/HDL ratio in albino rats.
The current research confirms that aqueous extract from stevia leaves may decrease the body weight gain, serum cholesterol, triglycerides, low density lipoprotein, very low density lipoprotein levels and LDL/HDL ratios. On the other hand, it improved the high density lipoprotein level of hyperlipidemic rats compared with untreated rats after eight weeks study period. It is concluded that aqueous extract of stevia with concentration 500 ppm/kg body weight of rats showed best results of all the parameters determined. It is confirmed from the results that stevia extract has hypolipidemic effects in albino rats. Nowadays obesity and hyperlipidemia are major health problems worldwide. As the diet of Pakistani population contained high amount of fat that’s why they are also facing health issues like obesity, hyperlipidemia and cardiovascular diseases. Therefore aqueous extract from Stevia leaves could be used as natural anti-hyperlipidemic drug for the treatment of hyperlipidemia and its associated complications. From the present research as it is proved that Stevia rebaudiana Bertoni leaves are non-toxic and safe for animals so it could be used for humans as part of their diet.
- BWG %:
Body weight gain percentage
High density lipoprotein
Low density lipoprotein
Very low density lipoprotein
El-Newary SA. The hypolipidemic effect of Portulaca oleracea L. stem on hyperlipidemic Wister albino rats. Annals of Agricultural Sciences. 2016;61(1):111–24.
Javed I, Rahman ZU, Khan MZ, Muhammad F, Aslam B, Iqbal Z, Sultan JI, Ahmad I. Antihyperlipidaemic efficacy of Trachyspermum ammi in albino rabbits. Acta Vet Brno. 2009;78:229–36.
Anbazhagan M, Kalpana M, Rajendran R, Natarajan V, Dhanavel D. In vitroproduction of Stevia rebaudiana Bertoni. EJFA. 2010;22(3):216–22.
Brahmachari G, Mandal LC, Roy R, Mondal S, Brahmachari AK. Stevioside and related compounds-molecules of pharmaceutical promise: a critical overview. Arch Pharm Chem Life Sci. 2011;(1):5–19.
Lemus-Mondaca R, Vega-Galvez A, Zura-Bravo L, Ah-Hen K. Stevia rebaudiana Bertoni, source of a high-potency natural sweetener: a comprehensive review on the biochemical, nutritional and functional aspects. J Food Chem. 2012;132:1121–32.
Stoyanova S, Genus J, Heideg E, Den Ende WV. The food additives insulin and stevioside counteract oxidative stress. Int J Food Sci Nutr. 2011;62:207–14.
Ferrazzano GF, Tiziana Cantile T, Brunella Alcidi B, Coda M, Aniello Ingenito A, Armando Zarrelli A, Fabio GD, Pollio A. Is Stevia rebaudiana Bertoni a non cariogenic sweetener? A Review Molecules. 2016;21:1.38. https://doi.org/10.3390/molecules21010038.
Sirisha K, Shivani J. Antihyperglycemic and Antihyperlipidemic activities of new Polyherbal formulations. JAPBC. 2014;3(1):189–98.
Ritu M, Nandini J. Nutritional composition of Stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect on patients with non-insulin dependent diabetes mellitus. J Sci Food Agric. 2016;96(12):4231–4.
Kujur RS, Singh V, Ram M, Yadava HN, Singh KK, Kumari S, Roy BK. Antidiabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan-induced diabetic rats. Pharm Res. 2010;2(4):258–63.
Abou-Arab AE, Abou-Arab AA, Abu-Salem MF. Physico-chemical assessment of natural sweeteners steviosides produced from Stevia rebaudiana Bertoni plant. Afri J Food Sci. 2010;4:269–81.
AOAC. Official methods of analysis of the Association of Official Analytical Chemists 17th Ed.; AOAC International, Gaithersburg, MD; 2000.
Iqbal Z, Ashraf T, Khan AA, Hussain R, Mudassar M. Antihyperlipidemic efficacy of cinnamon in albino rats. Asian J Agri Biol. 2016;4(1):8–16.
Uchida K, Satoh T, Ogura Y, Yamaga N, Yamada K. Effect of partial ileal bypass on cholesterol and bile acid metabolism in rats. Yanago. Acta Med Austriaca. 2001;44:69–77.
Stockbridge H, Hardy RI, Glueck CJ. Photometric determination of cholesterol (CHOD-PAP method). Ecoline® 2S, Merck KGaA, 64271 Darmstadt, Germany. J Lab Clin Med. 1989;114(2):142–51.
Annoni G, Botasso BM, Ciaci D, Donato MF, Tripodi A. Liquid triglycerides (GPO-PAP). Lab J Res Lab Med. 1982;9:115.
Assmann G. HDL-cholesterol precipitant. Randox labs. Ltd. Crumlin co., Antrim, N. Ireland. Internist. 1979;20:559.
Friedewald WT, Levy RI, Fredickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparation ultracentrifuge. Clin Chem. 1972;18:499–502.
Steel RGD, Torrie JH, Dickeyi D. Principles and Procedures of Statistics A biometrical approach. 3rd ed. New York: McGraw Hill Book Co. Inc; 1997. p. 336–52.
Onyeike EN, Monanu MO, Okoye CN. Changes in the blood lipid profile of wistar albinorats fed rich cholesterol diet. Annals Biological Research. 2012;3(11):5186–91.
Robarts MW, Wright JT. Sweetness without sugar. Dimeus Dent Hyg. 2010;8:58–61.
Abo Elnaga NIE, Massoud MI, Yousef MI, Mohamed Hayam A. Effect stevia sweetener consumption as non-caloric sweetening on body weight gain and biochemical’s parameters in over weight female rats. Annals of Agricultural Sciences. 2016;61(1):155–63.
Rajasekar P, Anuradha CV. Effect of L-carnitine on skeletal muscle lipids oxidative stress in rats fed high-fructose diet. Exp Diabetes Res. 2007;1:72–4.
Rains TM, Agarwal S, Maki KC. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem. 2011;22:1–7.
Abd El-Razek AM, Massoud MI. Biological evaluation of aqueous extract of Stevia rebaudiana leaves. Egypt J Food Sci. 2012;40:47–61.
Akbarzadeh S, Eskandari F, Tangestani H, Bagherinejad ST, Bargahi A, Bazzi P, Daneshi A, Sahrapoor A, O’Connor WJ, Rahbar AR. The effect of Stevia rebaudiana on serum omentin and visfatin level in stz-induced diabetic rats. J diet Suppl. 2015;12(1):1–12.
Assaei R, Mokarram P, Sanaz Dastghaib S, Darbandi S, Darbandi M, Fatemeh Zal F, Akmali M, Omrani GHR. Hypoglycemic effect of aquatic extract of Stevia in pancreas of diabetic rats: PPARγ-dependent regulation or antioxidant potential. Avicenna J Med Biotech. 2016;8(2):65–74.
Curry L, Roberts A. Subchronic toxicity of rebaudioside a. Food Chem Toxicol. 2008;46:S11–20.
Hossain MS, Alam MB, Asadujjaman M, Islam MM, Rahman MA, Islam MA, Islam A. Antihyperglycemic and anti hyperlipidemic effects of different fractions of stevia rebaudiana leaves in alloxan-induced diabetic rats. Int J Pharm Sci Res. 2011;2(7):1722–9.
Akbarzadeh S, Eskandari F, Tangestani H, Bagherinejad ST, Bargahi A, Bazzi P, Daneshi A, Sahrapoor A, WJ O’C, Rahbar AR. The effect of Stevia Rebaudiana on serum Omentin and Visfatin level in STZ-induced diabetic rats. J Diet Suppl. 2014; https://doi.org/10.3109/19390211.2014.901999.
Brijesh K, Kamath M. Experimental evaluation of anti-hyperglycemic and hypolipidemic effects of stevia rebaudiana, Anacardium occidentale on wistar rats. Int J Basic Clin Pharmacol. 2016;5(6):2463–7.
Sukla R, Gupta S, Gambhir JK. Antioxidant effect of aqueous extract of the bark of Ficus bengalensis in hypercholsterolaemic rabbits. J Ethanopharmacol. 2004;92:47–51.
Rajesh S, Rajesh Y, Elangovan M. Study of effect of Stevia rebaudiana bertoni on oxidative stress in type-2 diabetic rat models. Aging Pathol. 2012;2:126–31.
Singh S, Garg V, Yadav D. Antihyperglycemic and antioxidative ability of stevia rebaudiana (bertoni) leaves in diabetes induced mice. Int J Pharm Sci. 2013;5(2):297–302.
Prasad BS, Srinivasan KK, Harindran J. Chonemorpha Fragrans (moon) Alston-an effective anti-hyperglycemic and anti-hyperlipidemic agent in Streptozotocin Nicotinamide induced diabetic rats. Int J Pharm Sci Res. 2016;7(3):1149–55.
Salem AS. Effect of two carotenoids (lycopene and β-carotene) supplementation on hyperlipidemia and lipid peroxidation in experimental albino rats. J high institute of. Public Health. 2015;45(1):1–7.
The authors are thankful to the Institute of Home and Food Sciences, Government College University Faisalabad Pakistan for providing research facilities to prepare this valuable document.
No financial support was received in this research work.
Availability of data and materials
Available on request.
Ethics approval and consent to participate
Before doing the research, written informed consent was obtained from all fellows that participate in this experiment and ethical approval was obtained from Institutional Review Board Faculty of Science & Technology, Government College University, Faisalabad, Pakistan. The procedure followed the instructions of Good Laboratory Practice (GLP).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.